WESTLAKE VILLAGE, Calif., Sept. 22, 2015 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (NASDAQ:KYTH) today announced it has submitted an Investigational New Drug Application (IND) to...
Allergan and KYTHERA Announce that Pending Transaction will now be for All-Cash Consideration PR Newswire DUBLIN and WESTLAKE VILLAGE, Calif., Aug. 5, 2015 DUBLIN and WESTLAKE VILLAGE, Calif...
Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA PR Newswire DUBLIN and WESTLAKE VILLAGE, Calif., July 27, 2015...
Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of KYTHERA Biopharmaceuticals, Inc. Faruqi &...
Watch List for Drug Manufacturers - Major Equities -- Pfizer, Bristol-Myers Squibb, Eli Lilly, Kythera Biopharma, and Impax Laboratories PR Newswire NEW YORK, July 20, 2015 NEW YORK, July 20...
KYTHERA SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of KYTHERA Biopharmaceuticals, Inc. (KYTH) Over the Proposed Sale of the Company to Allergan plc. Faruqi &...
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Kythera Biopharmaceuticals, Inc. ("Kythera” or "the Company...
The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of KYTHERA Biopharmaceuticals, Inc. (NASDAQGS: KYTH) (“KYTHERA” or “the Company”) in...
Law Offices of Marc S. Henzel Announces Securities Class Action Periods PR Newswire MERION, Pa., June 23, 2015 MERION, Pa., June 23, 2015 /PRNewswire/ -- The Law Offices of Marc S. Henzel...
The Rosen Law Firm, a global investor rights law firm, announces that it is investigating the Board of Directors of Kythera Biopharmaceuticals Inc. (NASDAQ:KYTH) for possible breaches of...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관